WEARING A MASK IS STILL REQUIRED TO ENTER SUNNYBROOK. VISITORS AND PATIENTS MUST ALSO BE ASYMPTOMATIC & SHOULD BE FULLY VACCINATED. »

Cancer trials
Hospital  >  Care Programs  >  Odette Cancer Program  >  Clinical trials
Share:  
|

Cancer trials: Search results

Results: 18 items found.

Anakinra in Previously Untreated Chronic Lymphocytic Leukemia Patients (Anakinra)

Trial short name: Anakinra

Phase 1-2 Study of the Safety, Pharmacokinetics, and Preliminary Activity of ASTX660 in Subjects with Advanced Solid Tumors and Lymphomas

Trial short name: Astex 660

Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia (BRAWM)

Trial short name: Brawm

Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications

Trial short name: CHIP

A Phase 1/2, Open-Label, Dose-Escalation Trial of GEN3013 in Patients with Relapsed, Progressive or Refractory B-Cell Lymphoma (Genmab 01)

Trial short name: Genmab 01

A Study to Evaluate Imetelstat (GRN163L) in Transfusion-Dependent Subjects with IPSS Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) that is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment

Trial short name: Geron MDS Imerge

Sunnybrook Hematology Biobank (CMH Biobank)

Trial short name: Heme Biobank

Management of National MDS Clinical Database and Local Tissue Bank

Trial short name: MDS Database

A Phase III, International, Randomized, Controlled Study of Rigosertib Versus Physician's Choice of Treatment in Patients With Myelodysplastic Syndrome After Failure of a Hypomethylating Agent

Trial short name: Onconova MDS

A Phase II Study of Acalabrutinib in Combination with R-CHOP Chemotherapy in Previously Untreated Mantle Cell Lymphoma (OZM 109)

Trial short name: OZM 109

Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry

Trial short name: PNH Registry

Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients with Philadelphia Negative Myeloproliferative Neoplasms

Trial short name: Portal HTN

A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG-300) in Patients with Polycythemia Vera (PTG 300 11)

Trial short name: PTG 300 11